FI
ACER

Fosun International’s Acer Therapeutics Inc ACER Stock Holding History

Fosun International’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,700
Closed -$54K – 302
2019
Q2 		$54K Hold
15,700
– – ﹤0.01% 295
2019
Q1 		$373K Hold
15,700
– – 0.02% 240
2018
Q4 		$291K Buy
+15,700
New +$361K 0.02% 258

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fosun International's ACER Position: Q3 2019 in Review

Fosun International sold out of Acer Therapeutics Inc (ACER) in Q3 2019, closing a stake of 15,700 shares — an estimated $54K sold.

Fosun International first reported a position in ACER in Q4 2018 and held it in 3 quarters. The position peaked at $373K in Q1 2019. 40 funds tracked by Wall St. Rank hold ACER as of Q3 2019.

  • Fosun International reported no remaining Acer Therapeutics Inc position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 15,700 Acer Therapeutics Inc shares in Q3 2019, an estimated $54K.
  • Fosun International first reported a position in Acer Therapeutics Inc in Q4 2018 and held it in 3 quarters.
  • Fosun International's Acer Therapeutics Inc position peaked at $373K in Q1 2019.
  • 40 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.